Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

Dyax Corp. (DYAX)

-NasdaqGM
26.71 Down 0.06(0.22%) May 22, 4:00PM EDT
Add to Portfolio
Prev Close:26.77
Open:26.81
Bid:N/A
Ask:29.33 x 1000
1y Target Est:29.75
Beta:0.43
Earnings Date:Jul 27 - Jul 31 (Est.)
Day's Range:26.43 - 26.87
52wk Range:6.69 - 30.55
Volume:637,079
Avg Vol (3m):2,001,780
Market Cap:3.89B
P/E (ttm):N/A
EPS (ttm):-0.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXDown 0.22%3.89B
SHPGUp 0.74%51.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):44.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.19
Quarterly EPS Est (Jun-15) :-0.04
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-7.57

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback